You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
郭思治: 满贯集团(03390.HK)底子厚实拓新中式保健品牌 目标价2元
阿思达克 04-09 14:27
香港股票分析师协会副主席郭思治称,医疗板块一直备受中长线看好,尤其在疫苗开始接种後,零售业憧憬经济可望复苏,加上国策支持,以及市民疫情後更注重医疗健康产品等,均令资金流入医药相关股份。满贯集团(03390.HK)及健倍苗苗(02161.HK)昨晚(8日)出公告,将会成立合营企业,战略合作建立全新中式保健品品牌,抢攻大中华地区的千亿级大健康产业市场。今早满贯及健倍苗苗股价均见支持,表现不俗。

满贯集团为香港中成药行业三大分销商之一,代理分销逾百品牌,拥有丰富的品牌管理经验。去年疫情下自由行难以抵港,满贯大力拓展国内电商业务,在京东、天猫等知名平台开设网店,在面向全中国市场下,2020年全年电商销售收入近2.25亿港元,较2019年激增超过5倍,抢滩电商业务成功,更有利集团大湾区的业务拓展。满贯2020下半年亏损大幅收窄74%,加上电商业务带动,有望在2021年中期达亏转盈。

而健倍苗苗年初刚由雅各臣(02633.HK)分拆独立上市,旗下品牌如保济丸、何济公、唐太宗活络油等个个家传户晓,营收能力不容置疑,以健倍苗苗的品牌效应及研发生产能力,加上满贯的品牌管理经验及强大分销网络,令新品牌创立及推广事半功倍。

事实上满贯底子厚实,雅各臣为其基石投资者,即使早已过了禁售期可离场,但至今未尝减持股份,更增持了290万股;除了雅各臣及健倍苗苗,华润医药(03320.HK)亦是满贯股东之一,与集团有多方面合作。

上市近一年,满贯股价自年初开始发力,突破横行区,稳步上升,预期在疫苗产生效用後,自由行恢复带动零售市场转好,目标价2元,止蚀价1.45元。

(笔者为证监会持牌人)~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account